Literature DB >> 21858918

Effects of TiO2-containing phosphate glasses on solubility and in vitro biocompatibility.

G Novajra1, C Vitale-Brovarone, J C Knowles, G Maina, V Aina, D Ghigo, L Bergandi.   

Abstract

Phosphate-based glasses with different amounts of titanium dioxide (TiO(2)), having the following molar composition 50P(2)O(5)-30CaO-9Na(2)O-3SiO(2)-3MgO-(5-x)K(2)O-xTiO(2), (where x = 0, 2.5, 5 mol %), were synthesised and characterized in terms of solubility (according to ISO 10993-14), and in vitro biocompatibility using human MG-63 osteoblast cells. Dissolution tests were carried out in Tris-HCl (pH 7.4) to simulate the physiological pH and in citric acid (pH 3.0) to simulate an acidic environment. The weight loss decreased with increasing TiO(2) content, a process further enhanced in acidic medium. TiO(2) reduced the pH changes usually caused by the dissolution products released. Cellular tests showed that all the glasses studied (0-5 mol % TiO(2)) and TiCl(4), used to investigate the biocompatibility of titanium ions, did not produce cytotoxic effects on human MG-63 osteoblasts for up to 5 days in culture. On the basis of these results, we suggest that TiO(2)-containing phosphate glasses could be promising substrates for bone tissue engineering applications.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21858918     DOI: 10.1002/jbm.a.33186

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  2 in total

1.  Characterisation of CorGlaes(®) Pure 107 fibres for biomedical applications.

Authors:  Ross Colquhoun; Nikolaj Gadegaard; David M Healy; K Elizabeth Tanner
Journal:  J Mater Sci Mater Med       Date:  2016-08-31       Impact factor: 3.896

2.  Sensitivity of novel silicate and borate-based glass structures on in vitro bioactivity and degradation behaviour.

Authors:  Elena Mancuso; Oana Bretcanu; Martyn Marshall; Kenneth W Dalgarno
Journal:  Ceram Int       Date:  2017-10-15       Impact factor: 4.527

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.